Global Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Tenax Therapeutics

Market Cap: US$520.1m

A clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.

Jazz Pharmaceuticals

Market Cap: US$10.1b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

BioCryst Pharmaceuticals

Market Cap: US$1.5b

A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.

Ocugen

Market Cap: US$449.7m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.

Syncom Formulations (India)

Market Cap: ₹13.6b

Manufactures, markets, and sells pharmaceutical formulation products in India and internationally.

Aroa Biosurgery

Market Cap: AU$241.5m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

Lonza Group

Market Cap: CHF 37.4b

Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

Samsung BiologicsLtd

Market Cap: ₩80.2t

Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

COMPASS Pathways

Market Cap: US$596.3m

Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.

Collegium Pharmaceutical

Market Cap: US$1.6b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Ardelyx

Market Cap: US$1.4b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Outlook Therapeutics

Market Cap: US$91.9m

Operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.

BridgeBio Pharma

Market Cap: US$14.3b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Cypherpunk Technologies

Market Cap: US$53.0m

A biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer.

Nektar Therapeutics

Market Cap: US$895.0m

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

Summit Therapeutics

Market Cap: US$13.1b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

GT Biopharma

Market Cap: US$7.8m

A clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms.

Praxis Precision Medicines

Market Cap: US$6.7b

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.

ANI Pharmaceuticals

Market Cap: US$1.7b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Knight Therapeutics

Market Cap: CA$599.7m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Pulmatrix

Market Cap: US$13.6m

A clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States.

Viking Therapeutics

Market Cap: US$3.8b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

uniQure

Market Cap: US$1.5b

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

Veracyte

Market Cap: US$3.3b

Operates as a diagnostics company in the United States and internationally.

Compass Therapeutics

Market Cap: US$896.4m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

Evaxion

Market Cap: US$48.0m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

Omeros

Market Cap: US$649.4m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Acrivon Therapeutics

Market Cap: US$71.3m

A clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.

ChemoMetec

Market Cap: DKK 11.9b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

Arcturus Therapeutics Holdings

Market Cap: US$182.7m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

Edgewise Therapeutics

Market Cap: US$2.2b

A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.

Keros Therapeutics

Market Cap: US$613.3m

A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.

Ocular Therapeutix

Market Cap: US$2.8b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

Cardiol Therapeutics

Market Cap: CA$139.4m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Zai Lab

Market Cap: US$1.9b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Aurinia Pharmaceuticals

Market Cap: US$2.1b

A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.